A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Children's Oncology Group
University of Colorado, Denver
Ohio State University Comprehensive Cancer Center
Geneve TEAM Ambulances
Hospital Universitario Dr. Jose E. Gonzalez
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Gamida Cell ltd
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
National Research Center for Hematology, Russia
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital Los Angeles
University of Iowa
Newave Pharmaceutical Inc
CHU de Reims
University of Nebraska
M.D. Anderson Cancer Center
University of Pittsburgh
Center for International Blood and Marrow Transplant Research
Goethe University
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
National Cancer Institute (NCI)
University of Arizona
St. Jude Children's Research Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
Wugen, Inc.
Gazi University
University of Florida
McMaster University
Near East University, Turkey
Atlas University
Akdeniz University
Stanford University
Center for International Blood and Marrow Transplant Research
Institut Paoli-Calmettes
Massachusetts General Hospital
Medical University of South Carolina
Masonic Cancer Center, University of Minnesota
St. Petersburg State Pavlov Medical University
Indiana University
City of Hope Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Haukeland University Hospital